
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.
Journal: Leukemia & lymphoma
Published: August 17, 2026
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
'A perfect match': how hematologists discuss donor options and risks with black and white patients considering allogeneic stem cell transplant.
Journal: Leukemia & lymphoma
Published: May 07, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 03, 2025
Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Journal: JCO precision oncology
Published: June 07, 2024
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations.
Journal: JCO oncology practice
Published: January 19, 2024
Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes.
Journal: Patient education and counseling
Published: September 22, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Journal: The New England journal of medicine
Published: June 21, 2023
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 08, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: April 21, 2023
Last Updated: 09/26/2026